Contrasting effects of low-dose IL-2 on vaccine-boosted Simian Immunodeficiency Virus (SIV)-specific CD4+ and CD8+ T cells in macaques chronically infected with SIVmac251 Academic Article Article uri icon

Overview

MeSH Major

  • Immunity, Cellular
  • Interleukin-2
  • Single-Cell Analysis
  • T-Lymphocytes, Helper-Inducer
  • T-Lymphocytes, Regulatory

abstract

  • IL-2, the first cytokine discovered with T cell growth factor activity, is now known to have pleiotropic effects on T cells. For example, it can promote growth, survival, and differentiation of Ag-selected cells, or facilitate Ag-induced cell death of T cells when Ag persists, and in vivo, it is thought to contribute to the regulation of the size of adaptive T cell response. IL-2 is deficient in HIV-1 infection and has been used in the management of HIV-1-infected individuals undergoing antiretroviral therapy. In this study, we investigated how continuous low-dose IL-2 affected the CD4+ and CD8+ T cell response induced by two inoculations of a canarypox recombinant SIV-based vaccine candidate in healthy macaques chronically infected with SIVmac251. These macaques had normal levels of CD4+ T cells at the beginning of antiretroviral therapy treatment. Vaccination in the presence of IL-2 significantly augmented Gag-specific CD8+ T cell responses, but actually reduced Gag-specific CD4+ T cell responses. Although IL-2 at low doses did not change the overall concentration of circulating CD4+ or CD8+ T cells, it expanded the frequency of CD4+CD25+ T cells. Depletion of the CD4+CD25+ T cells in vitro, however, did not result in a reconstitution of Gag-specific CD4+ responses or augmentation of SIV-specific CD8+ T cell responses. Thus, we conclude that the decrease in virus-specific CD4+ T cell response may be due to IL-2-promoted redistribution of cells from the circulation, or due to Ag-induced cell death, rather than suppression by a T regulatory population.

publication date

  • February 15, 2005

Research

keywords

  • Academic Article

Identity

PubMed ID

  • 15699118

Additional Document Info

start page

  • 1913

end page

  • 21

volume

  • 174

number

  • 4